Caudill Cortney 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Caudill Cortney
SVP, CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2026-02-20+2,666→ 15,403 total - Tax Payment
Common Stock
[F1]2026-02-20$70.98/sh−1,037$73,606→ 14,366 total - Exercise/Conversion
Restricted Stock Units
[F2]2026-02-20−2,666→ 7,998 totalExercise: $0.00From: 2026-02-20→ Common Stock (2,666 underlying)
Footnotes (2)
- [F1]The reported disposition of 1,037 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Signature
/s/ James R. Oehler, Attorney-in-Fact|2026-02-24